Gastro-Intestinal Cancer Clinical Trial
Official title:
A Phase Ib Multiple Ascending Dose Study to Evaluate the Safety of Brivanib in Combination With 5-Fluorouracil/Leucovorin (5FU/LV) and Brivanib in Combination With 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) in Subjects With Advanced or Metastatic Gastrointestinal Malignancies
The purpose of this study is to determine a safe and maximum tolerable dose of Brivanib when combined with standard dose 5FU/LV and FOLFIRI.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02038114 -
The Impact of a Patient Education Intervention for Ambulatory Oncology Patients
|
N/A | |
| Recruiting |
NCT05509751 -
The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person
|
N/A | |
| Enrolling by invitation |
NCT05319145 -
PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study)
|
N/A | |
| Completed |
NCT02585362 -
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
|
N/A | |
| Recruiting |
NCT05332002 -
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
|
Phase 2 | |
| Withdrawn |
NCT05848843 -
A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations
|
Phase 1 |